Acuta Capital Partners’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-418,500	Closed	-$5.03M	–	44
2019 Q3	$5.03M	Sell	418,500 -253,000	-38%	-$3.04M	3.63%	9
2019 Q2	$8.13M	Buy	671,500 +334,000	+99%	+$4.04M	2.89%	13
2019 Q1	$4.24M	Buy	+337,500	New	+$4.24M	2.02%	20